DPP4 and neuropathic pain: In order to compare the pharmacological effect of CART peptides and IPI, the established DPP4 inhibitor, we tested CART fragments in an acute nociceptive tail-flick test and in carrageenan-induced subacute inflammatory hyperalgesia and partial nerve ligation-induced neuropathic pain models, in which IPI action was previously measured [33].